| 11 ديسمبر 2024م
ماجد خميس السلماني
أستاذ مساعد
علوم الأحياء الطبية
مركز أبحاث العلوم الطبيعية والطبية
محول: 762 البريد الإلكتروني: majid.al.salmani@unizwa.edu.om موقع المكتب: Building 25B. يعمل في الجامعة: منذ 2018
I am interested in investigating the mechanisms of ion transport across the plasma membranes of living cells. We focus on understanding the molecular defects that cause diseases such as cystic fibrosis. We employ electrophysiological, imaging and biochemical techniques to better understand the root cause of theses conditions.
أستاذ مساعد
علوم الأحياء الطبية
مركز أبحاث العلوم الطبيعية والطبية
I am interested in investigating the mechanisms of ion transport across the plasma membranes of living cells. We focus on understanding the molecular defects that cause diseases such as cystic fibrosis. We employ electrophysiological, imaging and biochemical techniques to better understand the root cause of theses conditions.
المؤهلات الأكاديمية
- دكتوراة، جامعة بريستول، 2017
- بكلوريوس العلوم ، جامعة جلاسكو، 2010
أنشطة التدريس
- Human Physiology، BIOL300
- Human Physiology Laboratory, BIOL300L
- Undergraduate lab projects
الأنشطة البحثية
- الاهتمامات البحثية
- Ion channels
- Channelopathies
- Cystic Fibrosis
- Cystic fibrosis transmembrane conductance regulator (CFTR)
- Long QT syndrome
- Human ether-a-go-go related gene (hERG) K+ channels
- حضور المؤتمرات
- New Roles for Ion Channels and Transporters in Health and Disease، UK (virtual)، 02/09/2021
- Electrophysiology & Imaging - a virtual Plymouth Workshop، Plymouth, UK (virtual)، 01/09/2021
- Physiology 2021 meeting، UK (Virtual)، 12/07/2021
- Young Physiologist meeting، Germany (Virtual)، 01/06/2021
- The First Biomedical Sciences Conference in Oman، Sultan Qaboos University، 26/02/2020
- 16th European Cystic Fibrosis Society Basic Science Conference، Dubrovnik (Croatia)، 27/03/2019
- EuroPhysiology2018، London (UK)، 13/08/2018
- المنشورات
- 1. 2022 Multiple mechanisms underlie reduced potassium conductance in the p.T1019PfsX38 variant of hERG، Al Salmani MK, Tavakoli R, Zaman W, Al Harrasi A. Physiol Rep. 2022 Jul;10(14):e15341. doi: 10.14814/phy2.15341. PMID: 35854468; PMCID: PMC9296870.
- 2. 2021 Molecular epidemiology of COVID-19 in Oman: A molecular and surveillance study for the early transmission of COVID-19 in the country، Al-Mahruqi S, Al-Wahaibi A, Khan AL, Al-Jardani A, Asaf S, Alkindi H, Al-Kharusi S, Al-Rawahi AN, Al-Rawahi A, Al-Salmani M, Al-Shukri I, Al-Busaidi A, Al-Abri SS, Al-Harrasi A. Int J Infect Dis. 2021 Jan 13;104:139-149. doi: 10.1016/j.ijid.2020.12.049. Epub ahead of print. PMID: 33359061; PMCID: PMC7834852.
- 3. 2015 The Cystic Fibrosis Symptom Progression Survey (CF-SPS) in Arabic: A Tool for Monitoring Patient`s Symptoms، Oman Medical Journal 30, 17-25.
- 4. 2015 A Specific Haplotype Framework Surrounds the Omani Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation S549R، Jordan Journal of Biological Sciences 8, 37 - 43.
- 5. 2014 Defining a mutational panel and predicting the prevalence of cystic fibrosis in Oman.، Sultan Qaboos Univ Med J. 14(3):e323-9.
- 1. 2020 Molecular Physiology and Pharmacology of the Cystic Fibrosis Transmembrane Conductance Regulator، Al Salmani M.K., Sondo E., Balut C., Sheppard D.N., Singh A.K., Pedemonte N. (2020) Molecular Physiology and Pharmacology of the Cystic Fibrosis Transmembrane Conductance Regulator. In: Hamilton K.L., Devor D.C. (eds) Studies of Epithelial Transporters and Ion Channels. Physiology in Health and Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-55454-5_16
- 2. 2014 Chapter 1: Features of the CFTR Cl- channel: relating structure to function، In ``Mutation-specific therapies in cystic fibrosis – Current status and prospects``; UNI-MED SCIENCE. Editor: Burkhard Tümmler
مقال:
قسم كتاب:
خدمة المجتمع
- 06/09/2021: Members of Jury, Falling Walls Lab 2021
- 30/05/2021: Animal ethics committee
- 08/11/2018: Biological ethics committee
العضوية في الهيئات المهنية
- 2021-الآن: The Physiological Society